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Abstract 
Background: Coronary calcification is associated with high risk for cardiovascular events. However, its impact on 
plaque vulnerability is incompletely understood. In the present study we defined the intrinsic calcification angle (ICA) 
as the angle externally projected by a vascular calcification and analyzed its role as novel feature of coronary plaque 
vulnerability in patients with type 2 diabetes.
Methods: Optical coherence tomography was used to determine ICA in 219 calcifications from 56 patients with 
stable coronary artery disease (CAD) and 143 calcifications from 36 patients with acute coronary syndrome (ACS). We 
then used finite elements analysis to gain mechanistic insight into the effects of ICA.
Results: Minimal (139.8 ± 32.8° vs. 165.6 ± 21.6°, p < 0.001) and mean ICA (164.1 ± 14.3° vs. 176.0 ± 8.4°, p < 0.001) 
were lower in ACS vs. stable CAD patients. Mean ICA predicted ACS with very good diagnostic efficiency (AUC = 0.840, 
95% CI 0.797–0.882, p < 0.001, optimal cut-off 175.9°); younger age (OR 0.95 per year, 95% CI 0.92–0.98, p = 0.002), 
male sex (OR 2.18, 95% CI 1.41–3.38, p < 0.001), lower HDL-cholesterol (OR 0.82 per 10 mg/dl, 95% CI 0.68–0.98, 
p = 0.029) and ACS (OR 14.71, 95% CI 8.47–25.64, p < 0.001) were determinants of ICA < 175.9°. A lower ICA predicted 
ACS (OR for 10°-variation 0.25, 95% CI 0.13–0.52, p < 0.001) independently from fibrous cap thickness, presence of 
macrophages or extension of lipid core. In finite elements analysis we confirmed that lower ICA causes increased 
stress on a lesion’s fibrous cap; this effect was potentiated in more superficial calcifications and adds to the destabiliz-
ing role of smaller calcifications.
Conclusion: Our clinical and mechanistic data for the first time identify ICA as a novel feature of coronary plaque 
vulnerability.
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Atherosclerosis, Diabetes mellitus
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Background
Coronary artery calcification (CAC) is a known fea-
ture of atherosclerosis [1] and extensive CAC is associ-
ated with a higher risk for cardiovascular events [1–3]. 
However, it has recently been suggested that not only 
CAC extent, but also its morphology may play a causal 
role in the development of acute coronary syndromes 
(ACS) [4, 5]. In fact, studies assessing the mechanics 
of the coronary plaque in the presence of microcalci-
fications highlighted that these small inclusions cause 
a significant increase in the peak circumferential stress 
exerted on the fibrous cap [6–8]. Such characteristics 
are only partially detected by computed tomography, 
which is being increasingly used in cardiovascular pre-
vention in order to assess CAC extent; on the other 
hand, optical coherence tomography (OCT) is used 
in studies assessing CAC morphology because of its 
excellent resolution and ability to detect calcifications 
[9–13]. Using intravascular imaging, previous stud-
ies found spotty calcifications, i.e. calcifications with a 
calcium arc < 90°, to be more frequent in patients with 
ACS compared to patients with stable coronary artery 
disease (stable CAD) [14–17] and to predict future 
revascularization [18]. These data, together with the 
previously cited mechanistic analyses [6–8], led to the 
hypothesis that small calcifications yield a destabilizing 
effect on coronary plaques, as opposed to the stabiliz-
ing effects of larger calcifications. However, this view is 
not unchallenged, as there are studies which—albeit in 
small populations—could not determine any difference 
in CAC morphology between ACS and stable CAD 
patients [10].
However, very little is known about morphological 
parameters of CAC besides the size of calcification as 
potential contributing factors to plaque vulnerability. 
Cardoso et  al. employed finite elements analysis on 
ex  vivo samples and could demonstrate that a prolate 
spheroid morphology of microcalcifications further 
increases the stress on the fibrous cap [19]. Still, noth-
ing is known about the geometrical properties of CAC 
which may influence plaque vulnerability. Thus, we 
aimed to analyze this aspect from a both clinical and 
mechanistic viewpoint using OCT and finite elements 
structural analysis.
To the best of our knowledge, we are first—among 
both theoretical models and in  vivo studies—to 1. 
define the intrinsic calcification angle (ICA, i.e. the 
angle externally projected by a vascular calcification) 
and to 2. test it as a novel parameter of plaque vulner-
ability in patients with type 2 diabetes. We selected a 
diabetic cohort because of its high cardiovascular risk 
and the high prevalence of vulnerable plaques in these 
patients.
Methods
Study population
In this study we analyzed 362 coronary calcifications 
from the target/culprit segments of 92 patients with type 
2 diabetes mellitus (T2DM) who underwent coronary 
angiography in the Department of Cardiology at the Uni-
versity Hospital of the RWTH Aachen. Inclusion criteria 
were presence of an at least intermediate coronary steno-
sis suitable for OCT—analysis, presence of CAC in the 
target/culprit segment as well as T2DM diagnosis. Defi-
nition of T2DM was based on an HbA1c > 6.5% and/or 
current antidiabetic therapy [20]. Detail of screening and 
inclusion are reported in Additional file  1: Figure S1. A 
subgroup of this population was part of previously pub-
lished analyses [12, 13].
Among the total 362 calcifications, 219 were from 56 
patients with stable CAD and 143 from 36 patients with 
ACS. Stable CAD was defined as no progression of fre-
quency and duration of clinical symptoms within the 
6  weeks preceding coronary angiography. In this case, 
the coronary target lesion was identified through echo-
cardiographic wall motion abnormalities, positive stress 
testing by MRT or echocardiography, and/or pathological 
fractional flow reserve (≤ 0.80) measurements. The ACS 
population was composed of patients with NSTEMI, 
defined as acute chest pain without ST-segment elevation 
and increased high-sensitivity cardiac troponin. Patients 
presenting with suspected type 2 myocardial infarction 
were not included in the present study.
Exclusion criteria were the localization of the lesion 
in the left main coronary artery, at a vessel bifurcation, 
in a previously implanted stent or in a bypass graft, as 
well as ongoing cardiogenic shock, acute or chronic kid-
ney disease (with serum creatinine > 1.5 mg/dl) or preg-
nancy. Glomerular filtration rate was estimated using the 
MDRD formula. Pre-procedural written informed con-
sent of all patients was obtained. The study was approved 
by the local ethics committee (EK 071/11 and EK 277/12) 
and is in accordance with the declaration of Helsinki on 
ethical principles for medical research involving human 
subjects.
Image acquisition
The OCT images were acquired prior to coronary inter-
vention in the coronary target/culprit segment using a 
frequency domain OCT C7XR system and the Dragon-
Fly catheter (St. Jude Medical Systems; Lightlab Imag-
ing Inc., Westford, Massachusetts, USA). If necessary, 
pre-dilatation was performed in order to allow advance-
ment of the OCT catheter. Pre-dilatation was performed 
on the interventionalist’s discretion and had an overall 
prevalence < 10%. Thrombus aspiration or thrombolysis 
were not performed in any patient. We obtained blood 
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removal by the injection of 14  ml contrast dye (iodix-
anol) at a flow rate of 4 ml/s through the guiding catheter. 
Image acquisition was obtained with automated pull-
back rate of 20  mm/s. Plaque analysis was performed 
offline by two independent observers throughout the tar-
get/culprit segment, defined as the whole length of the 
OCT pullback containing the target/culprit lesion steno-
sis, frame by frame in 0.2 mm intervals utilizing St. Jude’s 
proprietary software.
OCT‑based morphological analysis of calcification
In accordance to the standards for plaque morphology 
assessment using OCT, calcifications were defined as 
signal-poor heterogenous regions with clearly delineated 
contours [21]. Two calcifications were considered distinct 
when no continuity between them could be detected, i.e. 
when they were located on different portions of the vessel 
wall without any contact throughout their length or when 
they were longitudinally separated for at least 1 mm.
Morphologic parameters of CAC were assessed as pre-
viously described [12]. Furthermore, we defined a novel 
parameter, the intrinsic calcification angle (ICA), as the 
arc externally (i.e. abluminally) projected by a calcifica-
tion; a sample measurement is demonstrated in Fig.  1. 
This has to be kept distinct from the calcium arc, which 
measures the dimension of every calcification as the arc 
of vessel circumference (Additional file  2: Figure S2). 
ICA, on the contrary, is a parameter assessing calcifica-
tion geometry. In case of circumferential or irregular 
calcifications, the smallest ICA for every OCT-section 
was considered; examples of the measurement of such 
ICAs are shown in Additional file 2: Figure S2. Intra- and 
interobserver variability for minimal ICA were 0.965 and 
0.957, respectively.
Finite elements structural analysis
In order to gain mechanistic insight and to analyze the 
effects of changes in ICA on the mechanics of the coro-
nary plaque, we performed finite elements structural 
analysis using commercially available software. We simu-
lated the vessel as a hollow cylinder with a lumen diam-
eter of 1 mm and a vessel diameter of 3 mm. In analogy 
to previous models [7, 19], we simulated calcifications 
as rigid inclusions in an elastic material. We considered 
calcifications as compressible materials (with a Poisson`s 
ratio of 0.3) and the vessel wall as a nearly uncompress-
ible material (with a Poisson’s ratio of 0.45). The Young’s 
modulus of the calcification (10 GPa) and of the vessel 
wall (500  kPa) as well as the density of the calcification 
(2700  kg/m3) and of the vessel wall (1050  kg/m3) were 
extrapolated from previous literature [7, 19]. In order to 
exclude an influence of other parameters of calcification 
morphology on the peak cap stress, we initially set a cal-
cium arc of 60°, a depth of calcification of 100 µm and a 
calcification thickness of 0.5 mm as constants in the per-
formed simulations. In order to standardize the calcium 
arc and to be able to variate the ICA without affecting 
other parameters of calcification morphology, we pro-
posed a structure composed of an ellipsoid with a more 
superficial tetrahedron embedded in it. A pressure of 
110 mmHg (= 14.6 kPa) on the luminal side was applied 
as external load onto the lumen surface and a simulation 
of the structural stress in response to the load was per-
formed. We then analyzed the stress distribution as von 
Mises stress in a bi-dimensional cross section of the ves-
sel normal to the vessel axis, which included the calcifica-
tion. A graphical representation of the model is included 
in the Additional file 3: Figure S3. The stress intensity on 
the fibrous cap was graphically shown on a blue-red color 
scale and plotted against the distance from the lumen. 
The highest von Mises stress in the considered section 
was considered as peak cap stress.
Furthermore, in order to better characterize the impact 
of the various morphologic features of calcification on 
the stress increase due to ICA, we performed two simi-
lar analyses assuming ICAs of 20°, 40° and 70° as constant 
and variating respectively the depth of the calcification 
(in the range 50–500  µm) and the calcium arc (in the 
range 60°−80°). As outcomes we measured the absolute 
stress intensity and (only for the simulation assessing the 
depth of calcification) the stress concentration at 5  µm 
distance from the lumen.
Fig. 1 OCT–based measurement of ICA. The calcification is 
marked with a red square and is magnified. In this image, the angle 
abluminally projected by the calcification, i.e. the ICA, is marked. ICA 
intrinsic calcification angle
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Statistical analysis
Categorical variables were summarized as count (per-
centage), continuous variables as mean ± standard 
deviation. Distributions of continuous variables were 
compared with t test. The association of categorical vari-
ables was evaluated by Pearson’s Chi squared test. In 
statistical testing, we did not account for multiple calcifi-
cations in the same segment. To identify the optimal cut-
off-value of minimal and mean ICA to predict an ACS, 
we performed a receiver operating curve (ROC) analysis. 
Values with the highest Youden-index were identified as 
optimal cut-off-values. A classification of the diagnos-
tic efficiency according to the values of the area under 
the curve (AUC) was used as described elsewhere [22]. 
Univariate logistic regression analysis was performed 
to investigate which parameters predict a low ICA. Test 
results are reported as p-value (p), odds ratio (OR) and 
corresponding 95% confidence intervals (CI). Uni- and 
multivariate logistic regression analysis was also per-
formed to investigate if mean ICA and mean ICA < 175.9° 
predicts ACS independently from classical parameters of 
plaque vulnerability. Therefore, mean ICA was adjusted 
for minimal FCT, lipid volume index and the presence 
of macrophages, which are known to be determinants 
for the presence of ACS [23]. Mean ICA < 175.9° was not 
included in the multivariable model due to collinearity 
with mean ICA. All statistical analyses were performed 
with SPSS software (IBM Corp., Armonk, NY, USA). Sta-
tistical significance was awarded by p < 0.05.
Results
Population characteristics
Patients with ACS and stable CAD did not signifi-
cantly differ with respect to classical cardiovascular 
risk factors, complications of diabetes or medication. 
However, a higher HbA1c (7.7 ± 1.8% vs. 7.2 ± 1.6%, 
p = 0.008) and a trend towards a higher CRP (20.1 ± 31.6 
vs. 9.3 ± 11.6  mg/dl, p = 0.057) could be detected in 
patients with ACS compared to patients with sta-
ble CAD. Patients with ACS showed a thinner mini-
mal (51.3 ± 9.4 vs. 80.4 ± 27.0  µm, p < 0.001) and mean 
(97.2 ± 18.0 vs. 125.7 ± 29.5  µm, p < 0.001) fibrous cap 
thickness, a larger lipid volume index (1105.4 ± 343.8 vs. 
493.8 ± 361.2  mm*°, p < 0.001) and more often plaques 
with macrophages (25 (69.4%) vs. 23 (41.1%), p = 0.002) 
compared to patients with stable CAD. Further details 
are reported in Table 1.
ICA and further CAC morphology
Calcifications in patients with ACS demonstrated a sig-
nificantly lower minimal (139.8 ± 32.8° vs. 165.6 ± 21.6°, 
p < 0.001) and mean ICA (164.1 ± 14.3° vs. 176.0 ± 8.4°, 
p < 0.001) as compared to patients with stable CAD. 
Representative images are shown in Fig. 2. Other param-
eters of CAC were not different between patients with 
ACS compared to patients with stable CAD (Table  2). 
We found no difference in lesion localization in mini-
mal (LAD 160.4 ± 25.2°; LCX 155.1 ± 29.3°; RCA 
148.5 ± 33.2°) or mean ICA (LAD 173.5 ± 11.1°; LCX 
170.2 ± 12.8°; RCA 168.8 ± 14.0° all p = NS).
To evaluate the diagnostic value of ICA to predict ACS, 
logistic regression analysis was performed. Both minimal 
(OR 0.76 per 10° increase, 95% CI 0.69–0.83, p < 0.001) 
and mean ICA (OR 0.30 for 10° increase, 95% CI 0.22–
0.41, p < 0.001) predicted the presence of ACS.
Next, ROC-analyses were performed to evaluate the 
diagnostic efficiency of ICA to differentiate ACS from 
stable CAD. In the ROC-analysis reported in Fig.  3, we 
found that both minimal (AUC 0.778, 95% CI 0.731–
0.826, p < 0.001) and mean ICA (AUC 0.840, 95% CI 
0.797–0.882, p < 0.001) differentiated ACS from stable 
CAD with good/very good diagnostic efficiency. The 
optimal cut-off-values to individuate ACS were 167.5° 
(sensitivity at optimal cut-off: 63.9%, specificity at opti-
mal cut-off 77.6%) for minimal and 175.9° (sensitivity 
at optimal cut-off: 72.8%, specificity at optimal cut-off 
84.0%) for mean ICA. In univariate logistic regression 
analysis, a younger age (OR 0.95 per year, 95% CI 0.92–
0.98, p = 0.002), male sex (OR 2.18, 95% CI 1.41–3.38, 
p < 0.001), lower HDL-cholesterol (OR 0.82 per 10  mg/
dl, 95% CI 0.68–0.98, p = 0.029) and ACS (OR 14.71, 95% 
CI 8.47–25.64, p < 0.001) significantly predicted the pres-
ence of a mean ICA < 175.9°. Further data are reported in 
Table 3.
To investigate if ICA is associated with ACS indepen-
dently from classical features of the vulnerable plaque 
such as fibrous cap thickness, presence of macrophages 
and necrotic lipid core, multivariate logistic regression 
analysis was performed. In this analysis mean ICA was 
still and independently associated with ACS (OR for 
10°-variation 0.25 (95%-CI 0.13–0.52), p < 0.001). See 
Table 4 for further details.
Plaque rupture or calcified nodules and distance 
to minimal intrinsic angle
Of the 36 analyzed segments in patients with an ACS, we 
could detect a plaque rupture in 26 (72.2%) and a calcified 
nodule in 4 (11.1%). 24 calcifications were co-localized 
with plaque ruptures (14.2% of the calcifications in ACS 
patients), with 12 presenting as plaque ruptures alone 
(7.1%) and 12 presenting as calcified nodules (7.1%). The 
mean longitudinal distance between the sites of plaque 
rupture/calcified nodule and the minimal intrinsic angle 
in the considered calcification was 0.4 ± 0.5 mm (with an 
average length of calcification of 2.3 ± 2.9 mm). The site 
of the plaque rupture or calcified nodule was in 5 cases 
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Table 1 Population analysis
ACEi ACE-inhibitors, ACS acute coronary syndrome, BMI body mass index, BP blood pressure, ARB angiotensin receptor blockers, CABG coronary artery bypass graft, 
CAD coronary artery disease, CK creatin-kinase, CK-MB creatin-kinase muscle-brain, CRP C-reactive protein, FCT fibrous cap thickness, eGFR estimated glomerular 
filtration rate, HDL high density lipoprotein, LDH lactate dehydrogenase, LDL low density lipoprotein, PCI percutaneous coronary intervention
Stable CAD (n = 56) ACS (n = 36) P
Age (years) 70.4 ± 5.9 67.8 ± 9.2 0.171
Sex (male, n, %) 36 (64.3) 25 (69.4) 0.609
Hypertension (n, %) 49 (87.5) 23 (63.9) 0.365
Systolic BP (mmHg) 137.8 ± 19.6 137.0 ± 16.6 0.827
Current nicotine use (n, %) 9 (16.1) 10 (27.8) 0.176
Total pack years (pack years) 17.1 ± 22.2 18.2 ± 17.3 0.796
Positive family history (n, %) 25 (44.6) 12 (33.3) 0.280
Hyperlipidaemia (n, %) 39 (69.6) 23 (63.9) 0.566
BMI (kg/m2) 30.8 ± 4.6 29.4 ± 6.0 0.218
COPD (n, %) 6 (10.7) 5 (13.9) 0.647
Known CAD (n, %) 20 (35.7) 13 (36.1) 0.969
Previous PCI (n, %) 14 (25.0) 13 (36.1) 0.559
Previous CABG (n, %) 2 (3.6) 1 (2.8) 0.834
Diabetes severity
 Duration of diabetes (years) 11.4 ± 9.5 11.3 ± 10.5 0.943
 History of diabetic retinopathy (n, %) 10 (17.9) 8 (22.2) 0.606
 History of diabetic neuropathy (n, %) 20 (35.7) 8 (22.2) 0.170
 HbA1c (%) 7.2 ± 1.6 7.7 ± 1.8 0.008
Lab values
 Total cholesterol (mg/ml) 191.2 ± 45.1 187.1 ± 44.3 0.667
 LDL-cholesterol (mg/ml) 117.8 ± 36.4 113.0 ± 36.2 0.543
 HDL-cholesterol (mg/ml) 44.2 ± 10.3 42.5 ± 12.4 0.472
 Triglycerides (mg/dl) 181.8 ± 103.2 165.4 ± 95.2 0.454
 eGFR (ml/min/1.73 m2) 58.8 ± 6.5 58.1 ± 6.4 0.620
 BUN (mg/dl) 40.6 ± 14.5 40.2 ± 16.5 0.899
 Serum Creatinine (mg/dl) 1.0 ± 0.2 1.0 ± 0.3 0.927
 CRP (mg/ml) 9.3 ± 11.6 20.1 ± 31.6 0.057
 Creatine kinase at admission (U/l) 102.9 ± 60.1 190.1 ± 158.3 0.003
 LDH (U/l) 213.2 ± 66.4 245.4 ± 82.0 0.046
 Maximal troponin T (ng/ml) NA 487.4 ± 579.5 NA
 Maximal CK (U/l) NA 283.1 ± 215.7 NA
 Maximal CK-MB (U/l) NA 84.0 ± 16.9 NA
Medication pre-OCT
 Aspirin (n, %) 52 (92.9) 32 (88.9) 0.510
 Betablocker (n, %) 46 (82.1) 25 (71.4) 0.230
 ACE-i or ARB (n, %) 39 (72.2) 24 (68.8) 0.711
 Insulin (n, %) 26 (46.6) 14 (38.9) 0.476
 Metformin (n, %) 37 (66.1) 22 (61.1) 0.628
 Sulfonylureas (n, %) 13 (23.2) 5 (13.9) 0.271
 Incretins (n, %) 12 (21.4) 6 (16.7) 0.574
 Statin (n, %) 40 (71.4) 22 (61.1) 0.354
Plaque features in OCT
 Minimal FCT (µm) 80.4 ± 27.0 51.3 ± 9.4 < 0.001
 Mean FCT (µm) 125.7 ± 29.5 97.2 ± 18.0 < 0.001
 Lipid volume index (mm*°) 493.8 ± 361.1 1105.4 ± 343.8 < 0.001
 Presence of macrophages (n,  %) 23 (41.1) 25 (69.4) 0.002
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(20.8%) coincident with the site presenting the minimal 
ICA, and in further 9 cases (37.5%) only 0.2  mm away 
from it.
Finite elements structural analysis
After we found that a low ICA of a coronary artery calci-
fication is associated with ACS, finite elements structural 
analysis was performed to gain mechanistic insight into 
how changes in ICA as well as changes in depth of calcifi-
cation affect differences in fibrous cap stress. First, a small 
(30°) and large (180°) ICA were compared. In this analysis, 
we measured an up to 310% higher stress concentration 
(28 kPa for ICA = 30° vs. 9 kPa for ICA = 180°) in the pres-
ence of a smaller ICA as shown in Fig. 4a, b. The peak stress 
on the fibrous cap was exerted in the portion of the vessel 
wall immediately overlying the calcification. The spatial dis-
tributions are simulated and depicted in Figs. 4c, d.
Next, we investigated the impact of calcification depth 
on peak cap stress. In these analyses, more superficial 
calcifications caused higher absolute peak cap stress, 
as shown in Fig. 5a, b. As fibrous cap stress close to the 
luminal surface of the vessel wall is relevant for fibrous 
cap/plaque rupture, fibrous cap stress was investigated at 
5  µm depth. This analysis reveals that the stress on the 
fibrous cap at 5 µm is potentiated if depth of calcification 
is reduced (33 kPa for depth of 50 µm vs. 18 kPa for depth 
of 100  µm, 15  kPa for depth of 250  µm and 13  kPa for 
depth of 500 µm). This relationship is depicted in Fig. 5a 
for an ICA of 20° and remained consistent also in simula-
tions with different ICAs, as shown in Figs. 5b, c.
Fig. 2 Representative calcification morphology in patients with ACS and stable CAD. A lower ICA is seen in a calcification of a patient with ACS (a) 
in comparison to a calcification of a patient with stable CAD (b). ICA intrinsic calcification angle, ACS acute coronary syndrome, CAD coronary artery 
disease
Table 2 Analysis of calcification morphology
ICA intrinsic calcification angle
Stable CAD (n = 219) ACS (n = 143) p
Spotty calcification (n, %) 131 (59.8) 85 (59.4) 0.925
Mean calcium arc (°) 61.3 ± 40.5 62.8 ± 35.3 0.721
Maximal calcium arc (°) 92.7 ± 76.0 91.1 ± 65.1 0.836
Mean calcium depth (µm) 152.4 ± 99.0 146.0 ± 105.9 0.560
Minimal calcium depth (µm) 99.9 ± 97.1 96.6 ± 98.2 0.759
Mean calcium area  (mm2) 0.64 ± 0.62 0.67 ± 0.52 0.610
Maximal calcium area  (mm2) 1.17 ± 1.38 1.12 ± 1.03 0.681
Calcium length (mm) 1.77 ± 2.30 1.45 ± 1.42 0.101
Calcium volume index (°*mm) 170.0 ± 392.8 113.7 ± 172.9 0.063
Mean ICA (°) 176.0 ± 8.4 164.1 ± 14.3 < 0.001
Minimal ICA (°) 165.6 ± 21.6 139.8 ± 32.8 < 0.001
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Finally, we tested if the relationship between ICA and 
fibrous cap stress is dependent on the size of calcifica-
tion. As demonstrated in Fig.  5d, a smaller calcium arc 
increases the peak cap stress. However, the peak cap 
stress increases with smaller ICAs in all calcium arcs 
investigated, suggesting that the effect of ICA on the peak 
cap stress adds to the increased stress exerted by smaller 
calcifications.
Discussion
In this OCT analysis in patients with T2DM, we could 
demonstrate that coronary calcifications of patients with 
ACS present a significantly lower ICA compared to cal-
cifications in patients with stable CAD. Lower ICA is a 
determinant of ACS independently from other features of 
plaque vulnerability. Furthermore, finite elements struc-
tural analysis demonstrated that this novel morphological 
Fig. 3 Intrinsic calcification angle (ICA) as determinant of ACS. Receiver operating curves for the prediction of ACS for minimal (a) and mean (b) ICA. 
Abbreviation as in Fig. 2
Table 3 Univariate logistic analysis of  the  determinants 
of a mean ICA lower than 175.9°
OR (95% CI) p
Clinical parameters
 Age (per year) 0.95 (0.92–0.98) 0.002
 Sex (male) 2.18 (1.41–3.38) < 0.001
 ACS at presentation (present) 14.71 (8.47–25.64) < 0.001
 Hypertension (present) 0.75 (0.39–1.47) 0.408
 Systolic BP (per 10 mmHg) 0.98 (0.88–1.11) 0.797
 Current nicotine use (present) 1.11 (0.65–1.89) 0.703
 Total pack years (per 10 pack years) 1.06 (0.93–1.20) 0.374
 Positive family history (present) 0.68 (0.45–1.04) 0.078
 BMI (per kg/m2) 1.00 (0.97–1.03) 0.998
 COPD (present) 0.59 (0.30–1.17) 0.135
 Known CAD (present) 0.88 (0.57–1.35) 0.556
 Previous PCI (present) 1.20 (0.76–1.91) 0.430
 Previous CABG (present) 0.43 (0.15–1.28) 0.132
Diabetes severity
 Duration of diabetes (present) 1.00 (0.98–1.02) 0.840
 History of diabetic retinopathy (present) 1.40 (0.81–2.40) 0.228
 History of diabetic neuropathy (present) 1.02 (0.65–1.60) 0.936
 HbA1c (per  %) 0.97 (0.85–1.10) 0.634
Lab values
 Total cholesterol (per 10 mg/ml) 0.98 (0.93–1.03) 0.406
 LDL-cholesterol (per 10 mg/ml) 0.97 (0.91–1.03) 0.379
 HDL-cholesterol (per 10 mg/ml) 0.82 (0.68–0.98) 0.029
 Triglycerides (per 10 mg/dl) 0.99 (0.97–1.01) 0.277
 eGFR (per 10 ml/min/1.73 m2) 1.05 (0.75–1.46) 0.772
 CRP (per 10 mg/ml) 1.07 (0.95–1.21) 0.259
Table 4 Morphologic determinants of  ACS in  uni- 
and multivariate analysis
OR p
Univariate analysis
 Mean ICA (per 10°) 0.30 (0.22–0.41) < 0.001
 Mean ICA < 175.9° 14.7 (8.50–25.5) < 0.001
 Minimal FCT (per 10 µm) 0.34 (0.24–0.48) < 0.001
 Presence of macrophages (present) 1.68 (1.09–2.61) 0.020
 Lipid volume index (per 100 mm*°) 1.46 (1.32–1.61) < 0.001
Multivariate analysis
 Mean ICA (per 10°) 0.25 (0.13–0.52) < 0.001
 Minimal FCT (per 10 µm) 0.38 (0.25–0.59) 0.001
 Presence of macrophages (present) 3.09 (1.19–8.05) 0.021
 Lipid volume index (per 100 mm*°) 1.24 (1.10–1.40) 0.001
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parameter increases the stress on the fibrous cap. This 
phenomenon is potentiated if calcifications are smaller 
and more superficial.
So far, analyses regarding the impact of CAC on plaque 
vulnerability focused on the dimensions of calcifications, 
suggesting that smaller calcifications contribute to plaque 
vulnerability [4–8, 14–18] in addition to other estab-
lished parameters [23]. In the present study, we extend 
the current knowledge by demonstrating that a lower 
ICA is more frequently found in the culprit segments of 
patients with ACS than in the target segments of patients 
with stable CAD, suggesting that ICA may be a novel fea-
ture of the vulnerable plaque. We and others previously 
demonstrated that vulnerable plaques are characterized 
by a lower minimal FCT, a higher lipid volume index and 
a higher frequency of macrophage infiltration compared 
to stable plaques [23, 24]. With regard to minimal FCT, 
interventional studies demonstrated an increase of mini-
mal FCT using statin treatment [25, 26], suggesting that 
at least some of these features of plaque vulnerability may 
Fig. 4 Stress on the fibrous cap in dependence of the ICA in a finite elements structural analysis. A higher PCS can be seen in the fibrous cap 
directly overlying a calcification with a smaller ICA (30°, a) as compared to a calcification with an ICA of 180° (b). Spatial stress distributions are 
reported in C and D for these two scenarios. ICA intrinsic calcification angle, PCS peak cap stress. In a and b, vessel lumen is shown in white, and a 
calcification with different morphology is embedded in the vessel wall and contoured with a black line
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be influenced by pharmacological interventions. Fur-
ther studies are necessary to evaluate, if ICA responds to 
pharmacological treatment and reduces plaque vulner-
ability in patients.
We selected a cohort of patients with T2DM to assess 
the relevance of ICA as a novel feature of plaque vul-
nerability, provided that these patients more frequently 
exhibit a high-risk plaque phenotype [12, 24, 27, 28], 
which even starts with pre-diabetic conditions [29]. 
Often, patients with T2DM first present with more 
advanced CAD at ACS [30]. However, the existence of 
a relationship between T2DM and CAC morphology is 
still incompletely understood: some studies highlighted 
a more extensive calcification in the presence of T2DM 
[11, 28], while others showed no relevant difference in 
CAC morphology in patients with and without T2DM 
[12].
Finite elements analysis
Our observations were confirmed in finite elements 
structural analysis, in which we found a striking increase 
of the peak cap stress on the fibrous cap in the presence 
of a smaller ICA. It should be noted that the absolute 
increase is modest and that the calculated peak cap stress 
still remains below the critical threshold for rupture, 
which has been estimated at 300 kPa [31]. However, our 
finite elements model only takes into account the calcifi-
cation and its intrinsic angle as a potential destabilizing 
factor. Thus, in the context of a typical vulnerable plaque 
with a thin fibrous cap and a large necrotic core, the 
threefold increase in peak cap stress arising from a lower 
ICA could be more than sufficient to exceed the thresh-
old for rupture at 300 kPa.
Furthermore, we characterized how the relationship 
between ICA and peak cap stress is influenced by other 
morphological features of calcification. We could demon-
strate that more superficial calcifications cause a higher 
Fig. 5 Variation of the ICA-induced stress in dependence of calcification depth and dimensions. In (a) more superficial calcifications cause a higher 
absolute peak cap stress (black line) and, more importantly, a higher stress concentration at 5 µm depth from the lumen (green line). These effects 
remain consistent analyzing PCS (b) and stress at 5 µm depth (c) in a range of ICAs varying from 20° to 70°. The stress exerted on the fibrous cap by 
a calcification with a small ICA is also inversely related to the dimensions of the calcification itself, which is consistent throughout the whole range 
of analyzed ICAs (d). Abbreviation as in Fig. 4
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stress concentration in terms of absolute values and—
even more relevant—a higher stress concentration in the 
most superficial layers of the fibrous cap. This superficial 
stress concentration may therefore predispose to rupture 
of the fibrous cap and subsequently cause an ACS. Inter-
estingly, an almost twofold increase of the stress exerted 
at 5  µm occurs for calcification with a depth of 50  µm 
compared to calcifications with a depth of 100 µm, sug-
gesting that slight variations in this range may play a sig-
nificant biological role.
We also found an inverse correlation between the 
dimensions of the calcification and the peak cap stress, 
confirming the destabilizing effect of smaller calcifica-
tions which is in line with the findings of previous studies 
[5–9, 14–18]. Therefore, we can conclude that a smaller 
ICA of calcified particles under certain circumstances 
(i.e., a more superficial and/or less extensive calcification) 
poses an even greater risk for rupture by further increas-
ing fibrous cap stress.
Potential clinical relevance of ICA
Next, we analyzed the diagnostic efficiency of mean and 
minimal ICA to predict ACS. We found mean ICA to be 
a better determinant for ACS compared to minimal ICA. 
The clinical parameters predicting a mean ICA below the 
proposed best cut-off-value (175.9°) give further insight 
into this new morphological feature of plaque vulnerabil-
ity. In fact, some classical risk factors for atherosclerosis 
including male sex and a low HDL-cholesterol predicted 
the presence of lower ICA. Taken together, this novel 
feature of plaque vulnerability may be present more fre-
quently in a subpopulation of patients with increased 
cardiovascular risk. Interestingly, a lower ICA is also 
predicted by a younger age, a finding which may prompt 
further research on the evolution of CAC over time and 
on its relationship with plaque vulnerability. Further-
more, the role of CAC morphology rather than CAC 
quantification alone may explain some paradoxes such as 
the higher CAC scores presented by endurance athletes 
compared to age-adjusted inactive subjects on coronary 
CT [32]. In this light, vulnerability may not only be deter-
mined by the extent of calcification, but rather by its dis-
tribution and geometry—a hypothesis not only linked to 
ICA, but for instance also to the size of the calcifications 
(i.e., spotty/micro-calcifications). On the other hand, the 
apparent paradox of a more frequent subclinical CAD in 
endurance athletes may also be explained by possible det-
rimental effects of excess physical activity.
In the light of both our mechanistic and clinical data, it 
is tempting to speculate that ICA relevantly contributes 
to the development of ACS. As such, arrow-shaped vas-
cular calcifications with a low ICA may pose a threat to 
fibrous caps with subsequent plaque rupture resulting in 
ACS. However, ICA is only one of various morphologic 
features of plaque vulnerability and the interplay of all 
these factors should be taken into account when evaluat-
ing the net stability/vulnerability of a lesion.
Limitations
As this is the first study to define ICA and to evaluate 
its impact on the vulnerability of coronary plaques, our 
results have to be confirmed in larger populations, gen-
eralized to other study populations (e.g. non-diabetic 
patients) and evaluated in prospective trials. Particularly 
the limited patient number may affect the outcomes of 
our clinical study part with regard to some morphologi-
cal aspects of CAC such as its extension or the depth of 
the calcifications. These parameters may have a relevant 
role in the genesis of plaque vulnerability as our simula-
tion data suggest. Although our finite elements structural 
analysis data provide additional valuable mechanistic 
insight into how ICA impacts on plaque vulnerability, 
the observational nature of the clinical study part cannot 
prove causality. Moreover, as patients with kidney dis-
ease, who are in particular prone to vessel calcification, 
were excluded due to ethical reasons as the OCT inves-
tigation requires additional contrast media, we cannot 
draw any conclusion regarding this subpopulation. Fur-
thermore, as patients with severely calcified and tortuous 
lesions were not included in the study as this often does 
not allow the safe advancement of the OCT-catheter, we 
cannot exclude a potential selection bias with regard to 
the clinical part of this study. Besides, we cannot exclude 
any change in CAC morphology due to lesion pre-dilata-
tion. However, pre-dilatation was only performed if nec-
essary for the safe advancement of the OCT catheter in 
rare cases and profound changes in ICA are unlikely due 
to mechanical properties of CAC.
Furthermore, the finite elements model employed 
required several simplifying assumptions and was only 
elaborated to analyze the influence of ICA on the ves-
sel mechanics. Moreover, although the data showing a 
higher stress caused by low ICA in smaller calcifications 
are in line with the present literature, our analysis could 
be performed in a relatively small range of calcium arcs 
due to geometric limitations of the proposed model.
Conclusions
Our clinical and mechanistic data for the first time sug-
gest ICA to be a novel feature of coronary plaque vul-
nerability. The impact of ICA on fibrous cap stress is 
potentiated in more superficial calcifications and adds to 
the destabilizing role of smaller calcifications.
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